Pengyue Zhang

Computational Drug Discovery Methods Pharmacovigilance and Adverse Drug Reactions Statistical Methods in Clinical Trials Bioinformatics and Genomic Networks Pharmacogenetics and Drug Metabolism

Publications

Citations

983

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2013

Research summary

AI-generated

Pengyue Zhang works at the intersection of computer science, biomedical informatics, and pharmacology, developing computational and statistical methods to study drugs and diseases. This includes using artificial intelligence to find existing drugs that could be repurposed for conditions like Alzheimer's disease, monitoring drug safety in large health datasets, and analyzing clinical and population health data. The work combines machine learning, network modeling, and biostatistics applied to real-world medical questions.

Computational drug discovery and drug repurposingDrug safety and pharmacovigilanceStatistical methods for clinical trials and health dataBiomedical informatics and network medicineAI/machine learning for disease modeling

After a dip around 2022-2023, publication activity rose sharply in 2025, averaging about 3.4 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 3.4/year recently

Recent publications

2069-P: Risk of Suicidal Ideation and Behaviors, Depression, and Anxiety with GLP-1 Receptor Agonist Use in Children and Adolescents: A Target Trial Emulation Study
Diabetes · 2026
A decoupled dual-branch network for hyperspectral vehicle classification and camouflage recognition
Spectroscopy Letters · 2025
Association between onset age and mortality gradients in advanced cardiovascular–kidney–metabolic syndrome
Frontiers in Endocrinology · 2025
Novel Pulse Pressure Pattern Monitoring in Critical Care of Elderly Sepsis Patients
SSRN Electronic Journal · 2025
Novel pulse pressure pattern monitoring in critical care of elderly sepsis patients
Intensive and Critical Care Nursing · 2025
Global, regional, and national burdens of non-alcoholic fatty liver disease attributable to smoking from 1990 to 2021
Ecotoxicology and Environmental Safety · 2025
Distinct features of three clinical subtypes in 533 patients with primary hypertrophic osteoarthropathy
Orphanet Journal of Rare Diseases · 2025
Dual defects in HBsAg antigenicity and secretion caused by the C138R mutation in the S gene trigger occult hepatitis B virus infection
Journal of Translational Medicine · 2025
Global, regional, and national burdens of <i>Clostridioides difficile</i> infection over recent decades: a trend analysis informed by the Global Burden of Disease Study
Microbiology Spectrum · 2025
Abstract 4143792: Real-World Patterns of Statin Use, Titration, and Discontinuation Among a Racially Diverse Commercially-Insured Population
Circulation · 2024
Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease
Cell Reports Medicine · 2024
Additional file 1 of Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Figshare · 2022
Static hand gesture recognition based on hierarchical decision and classification of finger features
Science Progress · 2022
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Alzheimer s Research & Therapy · 2022
On Small-Sample Inference in Multiphase Stepped Wedge Cluster Randomized Trial (MSW-CRT) With Binary Outcomes
Research Square · 2021

Publishes in

Statistics in Medicine×4
CPT Pharmacometrics & Systems Pharmacology×4
medRxiv×3
Figshare×3
Clinical Pharmacology & Therapeutics×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile